Bacterial Infection of Liver: A Bird’s Eye View

Parvez, Mohammad K.; Niyazi, Sakina

doi:10.17554/j.issn.2224-3992.2016.05.624

Cited by 2 publications

(3 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, HBV can co-occur with non-communicable liver conditions including steatohepatitis and alcoholic liver disease. Although parasites such as liver flukes and biliary-tract bacterial infections also affect the liver, these are relatively less common [57]. Plasmodium species, the causative agent for malaria, asexually reproduces in the human liver as part of its life cycle.…”

Section: Comorbidities With Other Liver Pathogensmentioning

confidence: 99%

“…Studies on HBV and Plasmodium coinfection are few and sporadic, making prevalence estimations challenging. However, a 6% pooled prevalence rate has been reported, with places like Gambia and Nigeria reporting 10% and 7%, respectively [57]. It has been established that areas endemic for malaria and HBV infection largely overlap geographically.…”

Section: Comorbidities With Other Liver Pathogensmentioning

confidence: 99%

See 1 more Smart Citation

Hepatitis B Virus Infection: A Mini Review

Asandem,

Segbefia,

Kusi

et al. 2024

Viruses

View full text Add to dashboard Cite

Hepatitis B and C viruses (HBV and HCV) are the leading causes of end-stage liver disease worldwide. Although there is a potent vaccine against HBV, many new infections are recorded annually, especially in poorly resourced places which have lax vaccination policies. Again, as HBV has no cure and chronic infection is lifelong, vaccines cannot help those already infected. Studies to thoroughly understand the HBV biology and pathogenesis are limited, leaving much yet to be understood about the genomic features and their role in establishing and maintaining infection. The current knowledge of the impact on disease progression and response to treatment, especially in hyperendemic regions, is inadequate. This calls for in-depth studies on viral biology, mainly for the purposes of coming up with better management strategies for infected people and more effective preventative measures for others. This information could also point us in the direction of a cure. Here, we discuss the progress made in understanding the genomic basis of viral activities leading to the complex interplay of the virus and the host, which determines the outcome of HBV infection as well as the impact of coinfections.

show abstract

Section: Comorbidities With Other Liver Pathogensmentioning

confidence: 99%

Section: Comorbidities With Other Liver Pathogensmentioning

confidence: 99%

Hepatitis B Virus Infection: A Mini Review

Asandem,

Segbefia,

Kusi

et al. 2024

Viruses

View full text Add to dashboard Cite

show abstract

“…Mycobacterium tuberculosis , the causative agent of tuberculosis (TB) infection, had become resistant to one or more of the first‐line drugs, including isoniazid and rifampicin. Apart from S. pneumonia , other Gram‐negative bacterial strains had been identified with a wide range of infectious diseases, including meningitis, cellulitis, hemolytic infection, acute hepatitis, granulomatous hepatitis, and hepatic tuberculosis (Parvez & Niyazi, 2016; Stulberg et al., 2002). In recent years, the treatment of drug‐resistant TB would require longer treatment periods and more powerful drugs that may trigger more side effects.…”

Section: Introductionmentioning

confidence: 99%

Isolation and characterization of an antibacterial compound producing Stenotrophomonas strain from sewage water, production optimization, and its antibiotic potential evaluation

Sarkar

Nanda

Poddar

et al. 2021

Environmental Quality Mgmt

View full text Add to dashboard Cite

The increasing antibiotic resistance due to inappropriate administration of antibiotics is a huge concern for the scientific society, recurring the demand for novel antibiotics against antibiotic‐resistant bacteria. In this study, ABN18 bacterial strain was isolated from sewage wastewater with antibacterial substance production ability and was identified as Stenotrophomonas sp. by partial 16S rRNA sequencing. The isolated bacterial strain was Gram‐negative, long oval‐shaped, motile, nonendospore forming with an average length of 1.7025 μm determined by environmental scanning electron microscope (ESEM). Stenotrophomonas sp. ABN18 was found to have a flexible carbohydrate preference, only unable to grow in sorbitol. The strain showed moderate antibiotic resistance with significant sensitivity against antibiotics such as ceftazidime, doxycycline hydrochloride, and rifampicin. Antibacterial activity of ABN18 was found to be more active against Gram‐negative strains as compared with Gram‐positive bacterial strains. The well‐diffusion study confirmed the extracellular production of the antibacterial substance and its presence in the fermentation broth. Moreover, the temperature, pH, and incubation time were optimized at 33.17°C, 7.45, and 88.8 h, respectively, to maximize antibacterial substance production, and the highest zone of inhibition diameter of 22 mm against E. coli was achieved.

show abstract

Bacterial Infection of Liver: A Bird’s Eye View

Cited by 2 publications

References 20 publications

Hepatitis B Virus Infection: A Mini Review

Hepatitis B Virus Infection: A Mini Review

Isolation and characterization of an antibacterial compound producing Stenotrophomonas strain from sewage water, production optimization, and its antibiotic potential evaluation

Contact Info

Product

Resources

About